Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 69306-075

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 69306-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Doc Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7.5 mg Tablets (Cyclobenzaprine)

This is a description of Cyclobenzaprine HCI Tablets, USP 7.5mg with the quantity of 90. The tablets are distributed by Innovida Pharmaceutique Corporation and packaged by Enovachem Pharmaceuticals. The tablets are white, round, biconvex, and film-coated with the imprint RE:33. The National Drug Code (NDC) is 69306-075-09 and the Source NDC is 71800-003-01. The packaging shows a caution that federal law prohibits dispensing without a prescription and the tablets should be kept out of reach of children and stored at 20-25C (68-77F) [SEE USP CONTROLLED ROOM TEMP]. The Lot # and Exp Batch # are also provided.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.